Fortis Healthcare profit and loss

Latest FY26

Revenue: ₹9,128cr+17.3% on FY25
EBITDA: ₹2,085cr+31.3% on FY25
Net profit: ₹1,064cr+31.5% on FY25
EPS: ₹13.80+34.5% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	9,506	9,128	7,783	6,893	6,298	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	49.7	50.7	66.9	38.3	61.7
	9,556	9,179	7,850	6,931	6,359
	2,176	2,109	1,838	1,603	1,455
	−28.9	−20.0	−7.9	15.4	0.1
	1,388	1,297	1,167	1,120	1,047
	325	314	184	131	129
	470	449	386	343	316
	3,839	3,658	3,197	2,887	2,695
	8,170	7,807	6,765	6,099	5,641
	2,131	2,085	1,588	1,268	1,101
	1,662	1,636	1,202	925	786
Profit
	1,386	1,372	1,085	832	718
	−25.3	−22.2	−89.3	16.0	73.6
	1,361	1,350	996	848	792
	255	208	182	190	130
	53.5	93.2	15.4	22.8	50.7
	308	302	198	213	181
	17.8	16.4	11.5	9.5	21.8
	1,070	1,064	809	645	633
	1,052	1,048	798	636	611
	13.2	12.6	−3.5	1.8	−7.9
	1,083	1,077	806	647	625
	1,048	1,042	774	599	589
	22.3	22.4	35.2	46.3	44.3
Per share
	₹13.88	₹13.80	₹10.26	₹7.93	₹7.80
	₹13.88	₹13.80	₹10.26	₹7.93	₹7.80
Other comprehensive income — detail
	13.2	12.6	−3.5	—	—
	1.7	−1.0	−8.0	−2.2	−8.3
	0.4	−0.2	−2.0	—	—
	—	—	—	−0.5	−0.6
	—	13.3	2.5	3.4	−0.2
	−3.4	0.0	0.0	—	—
	1,061	1,055	771	601	—
	22.2	22.3	34.9	45.9	—
Per share — as-filed variants
	₹13.88	₹13.80	₹10.26	₹7.93	₹7.80
	₹13.88	₹13.80	₹10.26	₹7.93	₹7.80
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	7,359	7,039	5,953	5,274	4,843
	77.4%	77.1%	76.5%	76.5%	76.9%
Adjusted (ex-exceptional items) — derived
	1,386	1,372	1,085	832	718
	−25.3	−22.2	−89.3	16.0	73.6
	1,090	1,081	881	633	576
	₹14.13	₹14.02	₹11.17	₹7.78	₹7.10

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

FORTIS₹754.90

Fortis Healthcare Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersAPOLLOHOSP MAXHEALTH MEDANTA AUROPHARMA LUPIN ALKEM LAURUSLABS MANKINDMcap ₹56,992 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	6,297.6	6,892.9	7,782.8	9,127.8	9,506.2
Other Income	61.7	38.3	66.9	50.7	49.7
Total Income	6,359.4	6,931.2	7,849.7	9,178.5	9,555.9
Expenses
+ Purchases of Stock-in-Trade	1,454.7	1,603.3	1,838.1	2,108.7	2,176.4
+ Changes in Inventories	0.1	15.4	-7.9	-20.0	-28.9
+ Employee Benefit Expense	1,046.9	1,119.5	1,167.2	1,296.6	1,388.3
+ Finance Costs	129.1	131.0	184.4	314.5	325.3
+ Depreciation & Amortisation	315.7	342.5	385.6	449.4	469.8
+ Other Expenses	2,694.7	2,887.1	3,197.4	3,657.6	3,838.9
Total Expenses	5,641.1	6,098.7	6,764.8	7,806.8	8,169.9
EBITDA	1,101.3	1,267.6	1,587.9	2,085.0	2,131.4
EBIT	785.6	925.1	1,202.3	1,635.6	1,661.6
Profit
PBT before Exceptional Items	718.2	832.4	1,084.9	1,371.7	1,386.0
+ Exceptional Items	73.6	16.0	-89.3	-22.2	-25.3
Pretax Income	791.8	848.5	995.5	1,349.5	1,360.7
+ Current Tax	130.0	190.0	182.2	208.5	254.7
+ Deferred Tax	50.7	22.8	15.4	93.2	53.5
Tax Expense	180.7	212.8	197.7	301.7	308.3
+ Share of Associates & JVs	21.8	9.5	11.5	16.4	17.8
Net Income	633.0	645.2	809.4	1,064.2	1,070.2
+ Net Income — Continuing Ops	611.1	635.7	797.9	1,047.8	1,052.4
+ Other Comprehensive Income	-7.9	1.8	-3.5	12.6	13.2
Total Comprehensive Income	625.1	647.0	805.9	1,076.8	1,083.4
Net Income to Common	588.7	598.9	774.2	1,041.8	1,047.9
Minority Interest	44.3	46.3	35.2	22.4	22.3
Per Share
Basic EPS	7.80	7.93	10.26	13.80	13.88
Diluted EPS	7.80	7.93	10.26	13.80	13.88
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-3.5	12.6	13.2
+ Items NOT to be Reclassified to P&L	-8.3	-2.2	-8.0	-1.0	1.7
+ Tax on Items NOT to be Reclassified	—	—	-2.0	-0.2	0.4
+ Tax on Items NOT to be Reclassified — alt tag	-0.6	-0.5	—	—	—
+ Items to be Reclassified to P&L	-0.2	3.4	2.5	13.3	—
+ Tax on Items to be Reclassified	—	—	0.0	0.0	-3.4
Comprehensive Income — Owners of Parent	—	601.1	771.0	1,054.5	1,061.2
Comprehensive Income — Non-controlling Interests	—	45.9	34.9	22.3	22.2
Per Share — as-filed variants
Basic EPS — Continuing Operations	7.80	7.93	10.26	13.80	13.88
Diluted EPS — Continuing Operations	7.80	7.93	10.26	13.80	13.88
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	4,842.9	5,274.2	5,952.6	7,039.2	7,358.7
Gross Margin %	76.90	76.52	76.48	77.12	77.41
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	718.2	832.4	1,084.9	1,371.7	1,386.0
− Exceptional Items (reconciliation)	73.6	16.0	-89.3	-22.2	-25.3
Net Income Adj (tax-effected)	576.2	633.2	881.0	1,081.5	1,089.8
EPS Adj	7.10	7.78	11.17	14.02	14.13
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00
Filed Debt Equity	—	—	0.27	0.34	0.31
Filed Dscr	—	—	3.88	1.83	1.06
Filed Iscr	—	—	9.04	6.84	6.91
Paid Up Equity Capital	755.0	755.0	755.0	755.0	755.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.